Main > ONCOLOGY (**) > Gastric Cancer>MET or R PD-L1+*** > Treatment > USA. M. PembrolizuMAb>>

---

USA. M. PembrolizuMAb>>'s subsections
(*) USA Approval Date: 2017. 09.22
>& If .. HER2/neu-Targeted Therapy
>2 Prior Fluoropyrimidine- & Pt-CT
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.31.
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb>>'s products
This section has no products